Post-Acute Sequelae of COVID-19 clinical trials in California
14 active Post-Acute Sequelae of COVID-19 trials with a site in California. Describe your situation to see which ones look like a fit.
- Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- A Study to Examine Anktiva for the Treatment of COVID-19.
- A Study to Assess Anktiva in Patients With Long Covid-19.
- Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
- CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
- Water-based Activity to Enhance Recovery in Long COVID-19
- Acupuncture and Chinese Herbal Medicine for Long COVID
- Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
- Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC)
- The Long COVID-19 Wearable Device Study
- Cognitive Rehabilitation Therapy for COVID-19
- Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)
- Microbial and Cytokine Signatures in Long COVID Patients
- NE3107 in Adults With Neurological Symptoms of Long COVID
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.